Keyword: Bayer · 2 articles

United States FDA Approves Bayer's Novel Factor XIa Inhibitor Sunharbo to Prevent Recurrent Secondary Ischemic Stroke
Yesterday·635 words· …·Health Care
Bayer's Investigational FXIa Inhibitor Asundexian Granted FDA Priority Review Following 26 Percent Stroke Risk Reduction in Phase 3 Trial
11-08·928 words· …·U.S.

Newest first. Keywords are assigned per article when written, grouping stories about the same event or subject.